ArticleThe journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG2025
Recommendations for the Clinical Management and Prevention of Pediatric Cannabis Edible Ingestions.
Article in The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cannabis edible products pose significant health risks to children due to a wide variety of reasons. Currently, there is inconsistent governmental regulation and oversight for the manufacturing, packaging, and labeling of these products. Additionally, consumer education and harm reduction strategies are lacking, leading to an increase in the incidence of unintentional cannabis edible ingestions by the pediatric population. The variation of the components and potencies of cannabis products causes a wide range of dose-dependent adverse events within this patient population. This poses a significant challenge for clinicians treating pediatric patients who present with signs and symptoms consistent with cannabis intoxication. This article provides medical and pharmacological context on the current state of cannabis edibles in the United States, with further recommendations for the initial screening, management, and prevention of cannabis ingestions by pediatric patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.